(GNS) Genius - Ratings and Ratios

Exchange: NYSE MKT • Country: Singapore • Currency: USD • Type: Common Stock • ISIN: SGXZ34583559

GNS: Education, Home Childcare, Management Consultancy, Entrepreneur Training

Genius Group Limited (NYSE MKT: GNS) operates a global entrepreneur education system, offering business development tools, management consultancy services, and comprehensive educational programs. The company is divided into two primary segments: Education and Campus. Its curriculum is designed to provide entrepreneurs with a full suite of tools for both student learning and faculty earnings, focusing on practical skills and real-world application. Genius Group owns and operates entrepreneur resorts in Bali and South Africa, which host retreats and workshops. Additionally, it manages Genius Café, a beach club in Bali, and Genius Central, a co-working hub in Singapore.

The company also provides home childcare services, investment education, and operates entrepreneur education campuses offering programs from pre-primary to vocational levels. It delivers career-focused on-campus and online programs, including masters, bachelors, and associate degrees, as well as certificate and continuing education programs. Genius Group operates across multiple regions, including Europe, the Middle East, Africa, Asia, the Pacific, North America, and South America. Founded in 2002 and headquartered in Singapore, the company has established a global presence in the education services sector.

Genius Groups stock (GNS) is listed on the NYSE MKT under the ticker symbol GNS. The company is classified under the Education Services sub-industry with a market capitalization of $31.61 million USD. As of the latest data, the stock trades at $0.34, with a 20-day average volume of 5,710,739 shares. Key technical indicators include an ATR of 0.07, an SMA 20 of 0.40, SMA 50 of 0.52, and SMA 200 of 1.25. On the fundamental side, the company reports a P/E ratio of 0.30, forward P/E of 1.03, P/B of 0.59, and P/S of 1.96. However, the return on equity (RoE) is currently not reported.

3-Month Forecast:

Based on the provided technical and fundamental data, Genius Groups stock is expected to face downward pressure in the near term. The stock price is currently below its SMA 20, SMA 50, and SMA 200, indicating bearish momentum. The ATR of 0.07 suggests moderate volatility, but the overall trend remains negative. Fundamental analysis highlights a low P/E ratio of 0.30, which may indicate undervaluation, but the high P/S ratio of 1.96 signals potential overvaluation relative to revenue. The lack of RoE data adds uncertainty to the investment case. Over the next three months, the stock is likely to remain under pressure, with potential resistance at $0.40 (SMA 20) and support at $0.30 (current price level). Investors should monitor earnings reports and operational updates for further clarity.

Additional Sources for GNS Stock

GNS Stock Overview

Market Cap in USD 23m
Sector Consumer Defensive
Industry Education & Training Services
GiC Sub-Industry Education Services
IPO / Inception 2022-04-12

GNS Stock Ratings

Growth 5y -74.1%
Fundamental -1.47%
Dividend 0.0%
Rel. Strength Industry -95.3
Analysts -
Fair Price Momentum 0.30 USD
Fair Price DCF -

GNS Dividends

No Dividends Paid

GNS Growth Ratios

Growth Correlation 3m -90.8%
Growth Correlation 12m -96.4%
Growth Correlation 5y -88.4%
CAGR 5y -90.15%
CAGR/Max DD 5y -0.90
Sharpe Ratio 12m -2.81
Alpha -99.77
Beta 0.93
Volatility 155.07%
Current Volume 2076.3k
Average Volume 20d 2039.5k
What is the price of GNS stocks?
As of March 18, 2025, the stock is trading at USD 0.30 with a total of 2,076,335 shares traded.
Over the past week, the price has changed by +1.33%, over one month by -35.32%, over three months by -60.35% and over the past year by -94.83%.
Is Genius a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, Genius is currently (March 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of -1.47 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of GNS as of March 2025 is 0.30. This means that GNS is currently overvalued and has a potential downside of 0%.
Is GNS a buy, sell or hold?
Genius has no consensus analysts rating.
What are the forecast for GNS stock price target?
According to ValueRays Forecast Model, GNS Genius will be worth about 0.3 in March 2026. The stock is currently trading at 0.30. This means that the stock has a potential upside of +13.33%.
Issuer Forecast Upside
Wallstreet Target Price 6 1900%
Analysts Target Price 14.8 4833.3%
ValueRay Target Price 0.3 13.3%